Tavanta Therapeutics Announces New Preclinical Data for its Cystic Fibrosis Candidate TAVT-135 at Two Prominent Scientific Conferences
~ Data support potential for TAVT-135 to address significant unmet needs in people with cystic fibrosis, including those who are ineligible for, o...
Source: businessinsider.com